Deutsche Börse looking to marry Eurex with ISE

Mark Pengelly
30 Apr 2007

Tweet
Facebook
LinkedIn
Save this article
Send to
Print this page

Eurex is a joint venture between Deutsche Börse and the Zurich-based Swiss Exchange. The deal would value the ISE at $2.8 billion in cash, or $67.50 a share. Although Deutsche Börse’s executive has recommended the offer to its supervisory board, final terms and conditions have yet to be ironed out. Any deal would also be subject to shareholder and regulatory approval.

Suggestions of another transatlantic deal follow the finalisation of the merger between NYSE Group and European derivatives exchange Euronext in April. Deutsche Börse had also bid for Euronext, but pulled out of the running in November 2006.

A majority stake in Eurex’s former US subsidiary, now known as the US Futures Exchange, was sold to Man Group in July 2006.

Tweet
Facebook
LinkedIn
Save this article
Send to
Print this page

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact [email protected] or view our subscription options here: http://subscriptions.risk.net/subscribe

You are currently unable to print this content. Please contact [email protected] to find out more.

You are currently unable to copy this content. Please contact [email protected] to find out more.

You may share this content using our article tools. Printing this content is for the sole use of the Authorised User (named subscriber), as outlined in our terms and conditions - https://www.infopro-insight.com/terms-conditions/insight-subscriptions/

If you would like to purchase additional rights please email [email protected]

You may share this content using our article tools. Copying this content is for the sole use of the Authorised User (named subscriber), as outlined in our terms and conditions - https://www.infopro-insight.com/terms-conditions/insight-subscriptions/

If you would like to purchase additional rights please email [email protected]

You are currently on corporate access.